e 4031 has been researched along with Leukemia in 1 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zheng, F | 1 |
| Li, H | 1 |
| Du, W | 1 |
| Huang, S | 1 |
1 other study available for e 4031 and Leukemia
| Article | Year |
|---|---|
Role of hERG1 K(+) channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation.
Topics: Apoptosis; beta Catenin; Cell Cycle; Cell Proliferation; Chemokine CXCL12; Cyclin D1; Dose-Response | 2011 |